Epinephrine Market Players:
- Teva Pharmaceuticals Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amneal Pharmaceuticals, Inc.
- Adamis Pharmaceuticals Corporation
- Antares Pharma, Inc.
- Pfizer Inc.
- kaleo, Inc.
- ALK-Abelló A/S
- Bausch Health Companies Inc.
- Viatris Inc.
- Abbott Laboratories
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of epinephrine is assessed at USD 3.22 Billion.
The global epinephrine market size was valued at around USD 2.99 Billion in 2025 and is projected to grow at a CAGR of more than 8.4%, reaching USD 6.7 Billion revenue by 2035.
The North America epinephrine market holds the largest share by 2035, attributed to the rise in asthma and respiratory disease cases.
Key players in the market include Teva Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals, Inc., Adamis Pharmaceuticals Corporation, Antares Pharma, Inc., Pfizer Inc., kaleo, Inc., ALK-Abelló A/S, Bausch Health Companies Inc., Viatris Inc., Abbott Laboratories.
